Comparison of antibodies to MART-1 and MelanA in fine-needle aspiration samples of metastatic malignant melanoma [1]

Diagnostic Cytopathology

Volumn 25, Issue 1, 2001, Pages 78-79

  Fetsch, Patricia A ^a   Filie, Armando C ^a   Steinberg, Seth M ^a   Abati, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; MELAN A; MELAN A ANTIBODY; MELANOMA ANTIGEN; UNCLASSIFIED DRUG;

ASPIRATION BIOPSY; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LETTER; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SKIN PIGMENTATION; STAINING;

ADRENAL GLAND NEOPLASMS; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; BONE NEOPLASMS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MELANOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS;

EID: 0034936431     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.2007     Document Type: Letter

References (7)

1. An anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues
2. Production of recombinant MART-1 polyclonal and monoclonal antibodies: Use in the characterization of the human melanoma antigen MART-1
3. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas
4. Immunoreactivity for A103, an antibody to Melan-A (Mart-1), in adrenocortical and other steroid tumors
5. The new melanoma markers: MART-1 and Melan-A (the NIH experience)
6. Expression of Melan-A (MART-1) in benign melanocytic nevi and primary cutaneous malignant melanoma
7. Melanoma-associated antigen recognized by T cells (MART-1): The advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration